M1A.2791 Drug-induced chronic gout, unspecified ankle and foot, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Ankle and Foot, with Tophus (Tophi)

Summary

Drug-induced chronic gout, unspecified ankle and foot, with tophus (tophi) is a form of arthritis affecting the ankle and foot joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected areas.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the ankle and foot joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense ankle or foot pain, often with swelling and redness
• Persistent warmth and tenderness in the affected joints
• Formation of tophi (hard, painless lumps) around the ankle or foot
• Stiffness and limited range of motion in the affected joints
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history (including medication use), and laboratory tests to measure uric acid levels. Imaging studies, such as X-rays or ultrasound, may be used to detect tophi or joint damage. Joint fluid analysis can confirm the presence of urate crystals.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing or adjusting the causative medication, using urate-lowering therapies (e.g., allopurinol), and prescribing anti-inflammatory drugs for flare-ups. Tophi may require surgical intervention if they cause pain or functional impairment.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and further joint damage may be prevented. Regular monitoring of uric acid levels and medication adherence is essential. Follow-up care ensures treatment effectiveness and addresses any complications.

Complications

Untreated or poorly managed cases can lead to chronic joint damage, persistent pain, and increased tophi formation. Severe cases may result in deformity or loss of joint function.

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Manage weight and limit alcohol consumption

When to Seek Professional Help

Seek medical attention if experiencing severe joint pain, swelling, or redness, or if tophi are growing or causing discomfort. Prompt care can prevent progression and complications.

Tips for Medical Coders

Document the presence of tophi and the unspecified nature of the ankle and foot involvement. Ensure medication history is clearly recorded to support the drug-induced classification. Code M1A.2791 is specific to chronic gout with tophus in the unspecified ankle and foot region.